Vertaling van "use and developing " (Nederlands → Frans) :

The R&D (research and development) department of the FAMHP is responsible for the evaluation and approval of clinical research activities, ranging from the first “use” (concept) to extensive trials with medicines that are developed and carried out by university and other research centres and by the pharmaceutical industry.
The R&D (research and development) department of the FAMHP is responsible for the evaluation and approval of clinical research activities, ranging from the first “use” (concept) to extensive trials with medicines that are developed and carried out by university and other research centres and by the pharmaceutical industry.

From this starting point it proposes several areas on which to focus first and in which it would be useful to develop new models or at the very least, to optimise the facilities currently being used.
Partant de là, il propose différents champs d’action prioritaires dans lesquels il serait utile de développer de nouveaux modèles ou au minimum d’optimaliser les dispositifs existants.

The FAMHP intends to significantly increase its involvement in the lifecycle of immunological medicines for veterinary use by providing scientific advice, evaluating applications for clinical trials in Belgium, adopting (co-)rapporteurships for CP, MRP and DCP for MA of vaccines for veterinary use and developing pharmacovigilance and inspection activities.
The FAMHP intends to significantly increase its involvement in the lifecycle of immunological medicines for veterinary use by providing scientific advice, evaluating applications for clinical trials in Belgium, adopting (co-)rapporteurships for CP, MRP and DCP for MA of vaccines for veterinary use and developing pharmacovigilance and inspection activities.

FIELDS OF COMPETENCY 19 Activities of the operational departments 20 R&D (research and development) 20 Registration (marketing authorisation) 22 Vigilance 28 Production & Distribution 30 Proper Use of Medicines 38
FIELDS OF COMPETENCY 19 Activities of the operational departments 20 R&D (research and development) 20 Registration (marketing authorisation) 22 Vigilance 28 Production & Distribution 30 Proper Use of Medicines 38

The primary objectives of the SOE-USE in the initial phase are to train these employees and to develop an infrastructure which will enable collaboration and data exchange between members.
The primary objectives of the SOE-USE in the initial phase are to train these employees and to develop an infrastructure which will enable collaboration and data exchange between members.

“Ensuring, from development to use, the quality, safety and efficacy: ●● of medicines for human and veterinary
“Ensuring, from development to use, the quality, safety and efficacy: ●● of medicines for human and veterinary

Development in the number of registration applications for medicines for human use
Development in the number of registration applications for medicines for human use

Malaria kills a child under age five every 30 seconds in Africa Only 10% of R&D funds are used for research into 90% of the world’s health problems The NITD was granted USD 20 million in 2006 by the Wellcome Trust, the Singapore Economic Development Board and Medicines for Malaria Venture to initiate joint research on malaria Leprosy has dropped by over 90% since 1985 Deliveries for Coartem have climbed from four million treatments in 2004 to over 60 million in 2006
En Afrique, la malaria tue un enfant de moins de cinq ans toutes les 30 secondes Seuls 10% des fonds consacrés à la recherche sont investis dans les maladies qui représentent 90% des problèmes de santé dans le monde En 2006, l’Institut Novartis pour les maladies tropicales a obtenu du Wellcome Trust, du Singapore Economic Development Board et de Medicines for Malaria Venture USD 20 millions pour initier un programme commun de recherche sur la malaria Depuis 1985, la lèpre a diminué de plus de 90% Entre 2004 et 2006, les livraisons de Coartem sont passées de 4 millions à plus de 60 millions de traitements

The other classification system frequently used is the International Classification of Diseases, which deals with mental and behavioural disorders, 10 th revision, developed by the WHO and published in 1992.
L’autre système de classification couramment utilisé est la Classification Internationale des Maladies relative aux troubles mentaux et du comportement, 10 e révision, développée par l’OMS et publiée en 1992.

The SOE- USE’s first objectives are to train employees in their period of training and to develop an infrastructure that will make cooperation and the exchange of information between members possible.
The SOE- USE’s first objectives are to train employees in their period of training and to develop an infrastructure that will make cooperation and the exchange of information between members possible.